About Fluidda
Fluidda is a company based in Kontich (Belgium) founded in 2005. Fluidda has raised $2.81 million across 2 funding rounds from investors including Materialise and European Union. Fluidda offers products and services including Functional Respiratory Imaging and Broncholab. Fluidda operates in a competitive market with competitors including Polarean Imaging, Tomophase, Imbio, Cyclopharm and Bioxydyn, among others.
- Headquarter Kontich, Belgium
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fluidda India Medical Imaging Private Limited
- Date of Incorporation 11 Jan, 2011
- Jurisdiction Nashik, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
-$1.27 K (USD)0as on Mar 31, 2022
-
EBITDA
-$846.84 (USD)33.33as on Mar 31, 2022
-
Total Equity Funding
$2.81 M (USD)
in 2 rounds
-
Latest Funding Round
$2.81 M (USD), Private Equity Round
May 02, 2019
-
Investors
Materialise
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Fluidda
Fluidda offers a comprehensive portfolio of products and services, including Functional Respiratory Imaging and Broncholab.
Combines scans and dynamics for respiratory analysis and trials.
Assists in optimizing treatments for respiratory patients.
Funding Insights of Fluidda
Fluidda has successfully raised a total of $2.81M across 2 strategic funding rounds. The most recent funding activity was a Private Equity Round of $2.81 million completed in May 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Fluidda
Fluidda has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Materialise and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
3D printing software is developed for design and manufacturing needs.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Fluidda
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fluidda
Investment portfolio details for Fluidda
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fluidda
Detailed financials for Fluidda
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fluidda Comparisons
Peer comparison for Fluidda
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fluidda
Fluidda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Polarean Imaging, Tomophase, Imbio, Cyclopharm and Bioxydyn, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Noble gas polarizers for hyperpolarized pulmonary MRI are developed.
|
|
| Locked | Locked | Locked |
Endoscopic devices for respiratory disorders are developed using optical interferometry.
|
|
| Locked | Locked | Locked |
Medical imaging analysis for respiratory clinical support is provided.
|
|
| Locked | Locked | Locked |
Medical devices and radiopharmaceuticals for lung imaging are developed.
|
|
| Locked | Locked | Locked |
MRI-based diagnostic imaging services for respiratory disorders are offered.
|
Detailed competitors of Fluidda
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fluidda
Complete news archive for Fluidda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fluidda
Fluidda was founded in 2005 and raised its 1st funding round 6 years after it was founded.
Fluidda is headquartered in Kontich, Belgium. It is registered at Kontich, Antwerp, Belgium.
Fluidda is a funded company, having raised a total of $2.81M across 2 funding rounds to date.
Founded in 2005 in Kontich, Belgium, Fluidda operates within the respiratory health sector. Functional respiratory imaging is delivered through the integration of high-resolution CT scans and computational fluid dynamics. Contract research organization services are also extended to support clinical studies. Insights for personalized medicine are generated, facilitating diagnosis optimization, disease progression tracking, and treatment pathway refinements that address healthcare cost reductions.
Fluidda's top competitors include Polarean Imaging, Tomophase and Imbio.
Fluidda offers Functional Respiratory Imaging and Broncholab.
Fluidda has 2 investors. Key investors include Materialise, and European Union.